How the unfolding of notable infringement claim could alter commercial approaches for players in wider CBD treatment field.
David Knight
Advertisement
Articles by David Knight
Advertisement
Latest Updated Articles
Commercializing Cannabis and Patent LitigationFebruary 10th 2021
Advertisement
Advertisement
Trending on PharmExec
1
The Biotech Industry’s Relationship with Real-Time Data: Q&A with Dr. Richard Graham
2
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
3
Does FDA's Shift From Two Pivotal Trials to One Represent a Genuine Evolution?
4
Pharma M&A Roundup: Gilead Sciences Expands Collaboration with World Health Organization, Johnson & Johnson Enters Collaboration with Department of Health - Abu Dhabi
5